Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Thursday, January 7, 2010, 10:32AM ET - U.S. Markets close in 5 hours and 28 minutes. Dow Down 0.27% Nasdaq Down 0.50%
Martek Biosciences Corp. (MATK)At 10:17AM ET: 19.16  Down 0.14 (0.73%)  
MORE ON MATK
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Martek Biosciences Corp.
6480 Dobbin Road
Columbia, MD 21045
United States - Map
Phone: 410-740-0081
Fax: 410-740-2985
Web Site: http://www.martek.com

DETAILS 
Index Membership:S&P 600 SmallCap
S&P 1500 Super Comp
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:N/A

BUSINESS SUMMARY 
Martek Biosciences Corporation engages in the innovation and development of nutritional products from microbial sources, including algae, fungi, and other microbes worldwide. Its products include life'sDHA, a vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid) for use in infant formula, pregnancy and nursing products, foods and beverages, dietary supplements, and animal feeds; and life'sARA, a vegetarian source of the omega-6 fatty acid ARA (arachidonic acid) for use in infant formula. The company also provides contract manufacturing services for the production of enzymes, specialty chemicals, vitamins, and agricultural specialty products. It sells oils containing fatty acids under the names of life'sDHA, DHASCO, Neuromins, ARASCO, and life'sARA. The company markets its nutritional oils primarily to the infant formula, pregnancy and nursing, food and beverage, dietary supplement, and animal feed markets. Martek Biosciences Corporation was founded in 1985 and is headquartered in Columbia, Maryland.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Martek Biosciences Corp.


    CORPORATE GOVERNANCE 
    Martek Biosciences Corp.'s Corporate Governance Quotient (CGQ®) as of 3-Jan-10 is better than 92.2% of S&P 600 companies and 97.5% of Pharmaceuticals, Biotechnology & Life Sciences companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Mr. Steve Dubin , 56
    Chief Exec. Officer and Exec. Director
    $ 1.03M $ 0
    Mr. David M. Abramson , 57
    Pres
    $ 797.00K $ 0
    Mr. Peter L. Buzy , 50
    Chief Financial Officer, Principal Accounting Officer, Exec. VP of Fin. & Admin. and Treasurer
    $ 797.00K $ 631.00K
    Mr. Peter A. Nitze , 51
    Chief Operating Officer and Exec. VP
    $ 797.00K $ 0
    Mr. Barney B. Easterling , 64
    Sr. VP of Manufacturing
    $ 672.00K $ 0
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis